VarCov Co’s Stride LRN Stock Holding History

VarCov Co’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$676K	Buy	+7,835	New	+$720K	0.26%	134
2026 Q1	–	Sell	-9,766	Closed	-$634K	–	522
2025 Q4	$634K	Buy	+9,766	New	+$887K	0.25%	126

Other funds holding LRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

VarCov Co's LRN Position: Q2 2026 in Review

VarCov Co opened a new position in Stride (LRN) in Q2 2026: 7,835 shares worth $676K. The stake represents 0.26% of the portfolio and ranks #134 among its holdings. This is a return to the name: VarCov Co previously reported a position in LRN as recently as Q4 2025.

VarCov Co first reported a position in LRN in Q4 2025 and has held it in 2 quarters since. 410 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

VarCov Co held 7,835 shares of Stride worth $676K as of Q2 2026.
Stride was a new VarCov Co position in Q2 2026.
Stride made up 0.26% of VarCov Co's portfolio in Q2 2026, its #134 holding.
VarCov Co first reported a position in Stride in Q4 2025 and has held it in 2 quarters since.
410 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.